Citation Tools

Download PDFPDF

Extended report
Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis

Download to a citation manager

Cite this article as:
Sieper J, van der Heijde D, Dougados M, et al
Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis